Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Wealth and Cardiovascular Health: A Cross-Sectional Study of Wealth-Related Inequalities in the Awareness, Treatment and Control of Hypertension in High-, Middle- and Low-Income Countries Publisher Pubmed



Palafox B1 ; Mckee M1 ; Balabanova D1 ; Alhabib KF2 ; Bahonar A4 ; Ismail N5 ; Chifamba J6 ; Chow CK7 ; Corsi DJ8 ; Dagenais GR9 ; Diaz R10 ; Gupta R11 ; Iqbal R12 ; Kaur M13 Show All Authors
Authors
  1. Palafox B1
  2. Mckee M1
  3. Balabanova D1
  4. Alhabib KF2
  5. Bahonar A4
  6. Ismail N5
  7. Chifamba J6
  8. Chow CK7
  9. Corsi DJ8
  10. Dagenais GR9
  11. Diaz R10
  12. Gupta R11
  13. Iqbal R12
  14. Kaur M13
  15. Khatib R14
  16. Kruger A15
  17. Kruger IM16
  18. Lanas F17
  19. Lopezjaramillo P18
  20. Minfan F20
  21. Mohan V21
  22. Mony PK22
  23. Oguz A23
  24. Palileovillanueva LM24
  25. Perel P25, 26
  26. Poirier P27
  27. Rangarajan S28
  28. Rensheng L29
  29. Rosengren A30
  30. Soman B31
  31. Stuckler D32
  32. Subramanian SV33
  33. Teo K14
  34. Tsolekile LP34
  35. Wielgosz A35
  36. Yaguang P36
  37. Yeates K37
  38. Yongzhen M38
  39. Yusoff K39, 40
  40. Yusuf R41
  41. Yusufali A42
  42. Zatonska K43
  43. Yusuf S14

Source: International Journal for Equity in Health Published:2016


Abstract

Background: Effective policies to control hypertension require an understanding of its distribution in the population and the barriers people face along the pathway from detection through to treatment and control. One key factor is household wealth, which may enable or limit a household's ability to access health care services and adequately control such a chronic condition. This study aims to describe the scale and patterns of wealth-related inequalities in the awareness, treatment and control of hypertension in 21 countries using baseline data from the Prospective Urban and Rural Epidemiology study. Methods: A cross-section of 163,397 adults aged 35 to 70 years were recruited from 661 urban and rural communities in selected low-, middle- and high-income countries (complete data for this analysis from 151,619 participants). Using blood pressure measurements, self-reported health and household data, concentration indices adjusted for age, sex and urban-rural location, we estimate the magnitude of wealth-related inequalities in the levels of hypertension awareness, treatment, and control in each of the 21 country samples. Results: Overall, the magnitude of wealth-related inequalities in hypertension awareness, treatment, and control was observed to be higher in poorer than in richer countries. In poorer countries, levels of hypertension awareness and treatment tended to be higher among wealthier households; while a similar pro-rich distribution was observed for hypertension control in countries at all levels of economic development. In some countries, hypertension awareness was greater among the poor (Sweden, Argentina, Poland), as was treatment (Sweden, Poland) and control (Sweden). Conclusion: Inequality in hypertension management outcomes decreased as countries became richer, but the considerable variation in patterns of wealth-related inequality - even among countries at similar levels of economic development - underscores the importance of health systems in improving hypertension management for all. These findings show that some, but not all, countries, including those with limited resources, have been able to achieve more equitable management of hypertension; and strategies must be tailored to national contexts to achieve optimal impact at population level. © 2016 The Author(s).
Related Docs
View other Related Docs
1. Availability and Affordability of Blood Pressure-Lowering Medicines and the Effect on Blood Pressure Control in High-Income, Middle-Income, and Low-Income Countries: An Analysis of the Pure Study Data, The Lancet Public Health (2017)
2. Inequalities in the Use of Secondary Prevention of Cardiovascular Disease by Socioeconomic Status: Evidence From the Pure Observational Study, The Lancet Global Health (2018)
3. Prevalence, Awareness, Treatment and Control of Hypertension in Four Middle East Countries, Journal of Hypertension (2017)
Experts (# of related papers)
View all Related Experts
Roya Kelishadi (7)
Noushin Mohammadifard (5)
Other Related Docs
4. The Household Economic Burden of Non-Communicable Diseases in 18 Countries, BMJ Global Health (2020)
5. Socioeconomic Status and Risk of Cardiovascular Disease in 20 Low-Income, Middle-Income, and High-Income Countries: The Prospective Urban Rural Epidemiologic (Pure) Study, The Lancet Global Health (2019)
6. Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries, JAMA (2013)
7. Does Greater Individual Social Capital Improve the Management of Hypertension? Cross-National Analysis of 61 229 Individuals in 21 Countries, BMJ Global Health (2017)
8. Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the Pure Study, Diabetes Care (2020)
9. Variations in Common Diseases, Hospital Admissions, and Deaths in Middle-Aged Adults in 21 Countries From Five Continents (Pure): A Prospective Cohort Study, The Lancet (2020)
10. Variations Between Women and Men in Risk Factors, Treatments, Cardiovascular Disease Incidence, and Death in 27 High-Income, Middle-Income, and Low-Income Countries (Pure): A Prospective Cohort Study, The Lancet (2020)
11. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries, New England Journal of Medicine (2014)
12. Availability and Affordability of Medicines and Cardiovascular Outcomes in 21 High-Income, Middle-Income and Low-Income Countries, BMJ Global Health (2020)
13. Knowledge, Treatment, Control, and Risk Factors for Hypertension Among Adults in Southern Iran, International Journal of Hypertension (2015)
14. Use of Secondary Prevention Drugs for Cardiovascular Disease in the Community in High-Income, Middle-Income, and Low-Income Countries (The Pure Study): A Prospective Epidemiological Survey, The Lancet (2011)
15. The Effect of Physical Activity on Mortality and Cardiovascular Disease in 130 000 People From 17 High-Income, Middle-Income, and Low-Income Countries: The Pure Study, The Lancet (2017)
16. Associations of Fats and Carbohydrate Intake With Cardiovascular Disease and Mortality in 18 Countries From Five Continents (Pure): A Prospective Cohort Study, The Lancet (2017)
17. Availability and Affordability of Essential Medicines for Diabetes Across High-Income, Middle-Income, and Low-Income Countries: A Prospective Epidemiological Study, The Lancet Diabetes and Endocrinology (2018)
18. Long-Term Exposure to Outdoor and Household Air Pollution and Blood Pressure in the Prospective Urban and Rural Epidemiological (Pure) Study, Environmental Pollution (2020)
19. Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-Income, Middle-Income, and Low-Income Countries: An Analysis of the Pure Study Data, The Lancet (2016)
20. Urinary Sodium Excretion, Blood Pressure, Cardiovascular Disease, and Mortality: A Community-Level Prospective Epidemiological Cohort Study, The Lancet (2018)